Global Nerve Foundation

The National Center for Construction Education and Research (NCCER) is a nonprofit educational foundation committed to advancing the construction industry through industry-recognized training, assessments, and credentials. Established in 1996, NCCER focuses on building a skilled workforce by providing comprehensive education and workforce development solutions for various organizations including contractors, schools, and government entities. With nearly 30 years of expertise, NCCER offers a broad range of training programs and credentials that span all construction trades, supporting both emerging and experienced professionals. Their innovative initiatives, such as the Construction Leadership Series, aim to cultivate essential skills for future leaders while enhancing the overall effectiveness and performance of the construction workforce. Generated from the website

The Foundation for Applied Molecular Evolution (FfAME) is a pioneering research institution based in Alachua, Florida, dedicated to exploring the intersection of biology, chemistry, and other scientific disciplines to address fundamental questions about life and its origins. With a focus on innovative research in areas such as DNA technology, synthetic biology, and personalized medicine, FfAME aims to enhance our understanding of biological systems from the cellular level to the larger ecosystem. Founded by leading scientists, FfAME contributes significantly to advancements in medical genomics and systems biology. Through its outreach efforts and collaborations, the foundation engages with the scientific community and the public, fostering dialogue about the implications of its research on life's existence and the potential for extraterrestrial life. Generated from the website

Discovery Cure Institute, Inc. (DCI) is a certified 501(c)(3) Florida Non-Profit Corporation established in 2018, dedicated to the discovery of novel cures for cancer, infectious diseases, and CNS disorders. DCI leverages high-throughput and in silico screening techniques, supported by a library of 800,000 compounds acquired from the Sanford Burnham Prebys Medical Discovery Institute. With advanced capabilities in assay development, ultra high-throughput screening, and computational chemistry, DCI collaborates with Alchem Laboratories Corporation to rapidly identify active compounds that influence biomolecular pathways. The integrated technologies at the Alchem-DCI screening facility optimize the drug discovery process, moving from initial hit identification to lead generation and optimization. Generated from the website